Pain relieving effects of Botox injection in the hip joint following a periacetabular osteotomy
Patients with symptomatic hip dysplasia may undergo periacetabular osteotomy (PAO) and 10% of these patients have pain >6 months after the operation. An intra-articular lidocaine injection is used to determine if the pain comes from labral pathology in the hip joint or structures around the hip. To allow the patient a longer period of time to test the hip, we wanted to test if an intra-articular injection of Botox combined with local anaesthetic could reduce pain and allow the patient to test the hip. Eleven patients who received a PAO and suffered from persistent pain at least 6 months postoperative had an intra-articular joint injection with 100IE Botox, 3 ml NaCl water and 3 ml lidocaine. Hip pain on the day of injection and after 6 weeks was evaluated using the Visual Analog Scale score, International Hip Outcome Tool (iHOT-12), and Hip and Groin Outcome Score (HAGOS). Botox in the hip joint reduced the pain level and the iHOT-12 score, with a statistically significant improvement 6 weeks after injection. Hip joint injection of a controlled dosage of 100 IU diluted in 3 ml NaCl solution mixed with lidocaine had no side effects in this study with a limited group of patients. Botox has a promising pain-reducing effect on the hip joint in the majority of patients comparable with findings in knee and shoulder joints. Hip joint injection of a controlled dosage of 100 IU, 3 ml NaCl solution mixed with lidocaine had no side effects in this study with a limited group of patients.
Authors
- Niels Bang
- Bjarne Mygind‐Klavsen (ORCID: https://orcid.org/0000-0002-1438-854X)
- Bent Lund (ORCID: https://orcid.org/0000-0002-5339-8564)
- Casper Bindzus Foldager (ORCID: https://orcid.org/0000-0001-8729-0810)
- Stig Storgaard Jacobsen
Institutions
- Aarhus University Hospital (DK)
- Sana Kliniken AG (DE)
- Regionshospitalet Silkeborg (DK)
- Regional Hospital Horsens (DK)
Publication Details
- Journal
- Journal of Hip Preservation Surgery
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1093/jhps/hnaf019
- Citations
- 1
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39